MedTrace Logo

A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection

NCT05483660 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2022-08-02

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of Lactobacillus plantarum, Bacillus coagulans and Lactobacillus plantarum + Bacillus coagulans for eradication of Helicobacter Pylori, as well as the efficacy of Lactobacillus plantarum and Bacillus coagulans on side-effect caused by Helicobacter Pylori.

Conditions

  • Helicobacter Pylori Infection

Interventions

OTHER

Lactobacillus plantarum

1.5×10\^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.

OTHER

Bacillus coagulans

1.5×10\^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.

OTHER

Lactobacillus plantarum + Bacillus coagulans

1.5×10\^10 CFU probiotics and adult milk powder 15g per time , three times daily and half an hour before meal.

OTHER

Placebo

Adult milk powder 15 g pertime, three times daily and half an hour before meal.

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2024-08-31
Completion
2024-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05483660 on ClinicalTrials.gov